Objectives:
The aim of this study was to evaluate the effect of renal dose dopamine on renal function in diabetic patients undergoing coronary artery bypass surgery.Research Design: Conduction of a randomized, double-blind, clinical trial.Inclusion criteria: CABG surgery patients with heart bypass, diabetic patients, and patients with EF more than 30%Patients with BUN lower than 30 mg / dl, Patients with serum creatinine less than 5 mg / dl1.5Exclusion criteria: Age over 70 years, The combined surgical procedure, reoperation, The use of balloon pump, hyper-thyroidism, patients with contraindications for use dopamine such as pheochromocytoma, dialysis for history of Renal Failure, patients with serum creatinine equal to or more than 1.5 dl / mg, patients with EF equal and less than 30%, patients with BUN more than 30 dl / mg, patients with kidney and liver problems, patients who we had to use a higher dose of 0.05 isotropic in the operating room and ICU, The left ventricular dysfunction.To determine the effect of renal dose dopamine in diabetic patients undergoing coronary artery bypass surgery at 7am in the first, second and third days after surgery and 1 hours after surgery CR,BUN,K ,Cr CLEARANCE will be measured . Interventions: In this randomized study, 86 patients with normal renal function will randomly assign into two groups. Group dopamine receives infusion of 3 µg / kg / min dopamine to 24 hours after the induction of the anesthesia but the control group does not receive medical treatment.